(Q41685315)

7 October 2017

1 reference

title

The impact of indirect costs on outcomes of health care programs (English)

1 reference

7 October 2017

Koopmanschap MA

1

1 reference

7 October 2017

Rutten FF

series ordinal

2

1 reference

7 October 2017

language of work or name

English

0 references

publication date

1 November 1994

1 reference

7 October 2017

1 reference

7 October 2017

volume

3

1 reference

7 October 2017

issue

6

1 reference

7 October 2017

page(s)

385-393

1 reference

Towards a new approach for estimating indirect costs of disease

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030606

7 January 2021

Indirect costs in economic studies: confronting the confusion

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030606

7 January 2021

Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030606

7 January 2021

Economic aspects of cervical cancer screening

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030606

7 January 2021

Diagnostic and treatment procedures induced by cervical cancer screening

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030606

7 January 2021

Effects of ACE inhibitors on heart failure in The Netherlands: a pharmacoeconomic model

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030606

7 January 2021

The effects of cimetidine on the cost of ulcer disease in Sweden

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030606

7 January 2021

Biological basis of stress-related mortality

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030606

7 January 2021

A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030606

7 January 2021

Cost-effectiveness of thrombolysis--a randomized study of intravenous rt-PA in suspected myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030606

7 January 2021

Discounting in the economic evaluation of health care interventions

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030606

7 January 2021

QALY league tables: handle with care

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730030606

7 January 2021

Identifiers

DOI

10.1002/HEC.4730030606

1 reference

7 October 2017

1 reference